Biovest International, Inc.'s CEO to Discuss Pending Milestones for its Anti-Cancer Vaccine, BiovaxID(R), on Wall Street TV and at Las Vegas Small Cap Investment Conference

TAMPA, Fla.--(BUSINESS WIRE)--Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), today announced that its Chairman and CEO, Dr. Steven Arikian, is scheduled to be interviewed on the “3 Minute Press Show,” an internet financial news program hosted by Tracee Tolentino and featured on Wall Street TV. The broadcast will air on Friday, April 25, 2008 and can be accessed at: http://tv.wallst.net
MORE ON THIS TOPIC